Funder directory / Switzerland / Venture capital firms
Nextech Invest
Nextech Invest is a Zurich-based venture capital firm that invests in emerging biotechnology companies worldwide. It focuses on identifying and supporting transformative cancer medicines and advances in precision medicine.
StagesNot stated
Deals recorded9
What they invest in
Latest investments
All 9 dealsPRO| Company | Round | Amount | Date | Co-investors | Source |
|---|---|---|---|---|---|
| ARS Pharmaceuticals | – | – | – | – | Portfolio page |
| Arrakis Therapeutics US | – | – | – | – | Portfolio page |
| Ambrx Biopharma | – | – | – | – | Portfolio page |
| Ambagon Therapeutics | – | – | – | – | Portfolio page |
| Alumis | – | – | – | – | Portfolio page |
Exits
- Ambrx Biopharma Acquired by Johnson & Johnson2024 · Source
Shown only when an exit is documented by a public source.
Similar funders
- Alpana Ventures · Venture capital, Switzerland
- b2venture · Venture capital, Switzerland
- BioMedPartners · Venture capital, Switzerland
- BlueOcean Ventures · Venture capital, Switzerland
- Endeavour Vision · Venture capital, Switzerland
- HBM Partners · Venture capital, Switzerland